Benefits of Extended-Release Memantine in Moderate-to-Severe Alzheimer's Disease as a Function of Disease Severity: Post Hoc Analysis from a Randomized Trial: T2317.


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles